Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor.

BMC Cancer · 2008 · PMC2613414 · PMID 19040731

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Notably, after 12 h of A-192621 treatment, there are highly significant increases in the expression of several genes known to be up-regulated following DNA damage.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.